AU2003283427A1 - Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) - Google Patents
Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)Info
- Publication number
- AU2003283427A1 AU2003283427A1 AU2003283427A AU2003283427A AU2003283427A1 AU 2003283427 A1 AU2003283427 A1 AU 2003283427A1 AU 2003283427 A AU2003283427 A AU 2003283427A AU 2003283427 A AU2003283427 A AU 2003283427A AU 2003283427 A1 AU2003283427 A1 AU 2003283427A1
- Authority
- AU
- Australia
- Prior art keywords
- pde9a1
- phosphodiesterase
- therapeutics
- diagnostics
- diseases associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02027531.9 | 2002-12-09 | ||
| EP02027531 | 2002-12-09 | ||
| PCT/EP2003/013282 WO2004053495A1 (en) | 2002-12-09 | 2003-11-26 | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003283427A1 true AU2003283427A1 (en) | 2004-06-30 |
Family
ID=32479717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003283427A Abandoned AU2003283427A1 (en) | 2002-12-09 | 2003-11-26 | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1573331A1 (en) |
| AU (1) | AU2003283427A1 (en) |
| WO (1) | WO2004053495A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005103241A1 (en) * | 2004-04-26 | 2005-11-03 | Pfizer Products Inc. | Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase 9a (pde9a) and uses thereof |
| DE102005024494A1 (en) * | 2005-05-27 | 2006-11-30 | Bayer Healthcare Ag | Use of cyanopyrimidines |
| EP2123301A4 (en) * | 2006-12-13 | 2010-11-03 | Aska Pharm Co Ltd | Therapeutic agent for urinary tract disease |
| CN102459645B (en) | 2009-05-12 | 2023-05-30 | 皇家飞利浦电子股份有限公司 | Phosphodiesterase 9A as a marker for prostate cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922595A (en) * | 1997-12-09 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Cyclic GMP phosphodiesterase |
| EP1474528A4 (en) * | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
-
2003
- 2003-11-26 AU AU2003283427A patent/AU2003283427A1/en not_active Abandoned
- 2003-11-26 EP EP03775392A patent/EP1573331A1/en not_active Ceased
- 2003-11-26 WO PCT/EP2003/013282 patent/WO2004053495A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1573331A1 (en) | 2005-09-14 |
| WO2004053495A1 (en) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003276220A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) | |
| AU2003301894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
| AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
| AU2003210518A1 (en) | Molecules for diagnostics and therapeutics | |
| AU2003276136A1 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003283303A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
| AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
| AU2003239589A1 (en) | Eta-1 gene and methods for use | |
| AU2003274083A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
| AU2003267380A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
| AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor | |
| AU2003289894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) | |
| AU2003279323A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
| AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
| AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003294206A1 (en) | Methods for diagnosing htlv-i-mediated diseases | |
| AU2003288171A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) | |
| AU2003288158A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
| AU2003283302A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) | |
| AU2003276187A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) | |
| AU2003282087A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) | |
| AU2003279322A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
| AU2003245981A1 (en) | Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |